Previous Close | 0.0350 |
Open | 0.0350 |
Bid | 0.0350 x N/A |
Ask | 0.0350 x N/A |
Day's Range | 0.0350 - 0.0350 |
52 Week Range | 0.0200 - 0.1750 |
Volume | |
Avg. Volume | 29,945 |
Market Cap | 2.014M |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1200 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" "Kovo") - a leader in healthcare technology and Billing-as-a-Service - today reported its annual financial results for the period ending December 31, 2023.Key Metrics:Securing a $3.3 million equity investment in April 2023.Securing a US$7.0 million credit facility in April 2023.Successful completion of the acquisition of E&A Medical Billing in April 2023.Completion of the acquis
Kovo HealthTech ( CVE:KOVO ) Full Year 2023 Results Key Financial Results Revenue: US$10.0m (down 5.0% from FY 2022...
Vancouver, British Columbia--(Newsfile Corp. - April 3, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" or "Kovo") - a leader in healthcare Billing-as-a-Service - announces a forbearance agreement with its primary lender Avonlea Ventures #2 Inc. ("AVI"), a corporation wholly-owned by Micheal Steele, a director of Kovo.Kovo's primary lender, AVI entered into a forbearance agreement (the "Forbearance Agreement") dated February 27th, 2024 in connection with the investment agreement